IP Library › Granted Patent US 7,166,692
Granted Patent B2
US 7,166,692 · App. 10/790,768 · Granted Jan 23, 2007

Intracellular delivery of small molecules, proteins, and nucleic acids

Assignee: Canbrex Bio Science Walkersville, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,166,692
App. No.
10/790,768
Granted
Jan 23, 2007
Kind
B2
Abstract

An amino acid sequence Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1) functions as a protein transduction domain (PTD) and is capable of delivering small molecules, proteins, and nucleic acids to an intracellular compartment of a cell. An amino terminal lysine linker improves the efficiency of the PTD. A nuclear localization signal can be used to target the PTD to a cell's nucleus. The PTD can be used in PTD-cargo moiety complexes that can reversibly immortalize cells and increase cell viability in culture.

Claims (15)

1. An isolated and purified polypeptide with a protein transduction domain (PTD) which comprises Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1), wherein the polypeptide can traverse a cellular membrane.

2. The polypeptide of claim 1 further comprising at its amino terminus Lys-Xaa-Xaa, wherein Xaa is a small neutral polar or nonpolar amino acid.

3. The polypeptide of claim 2 comprising the amino acid sequence Lys-Gly-Gly-Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:2).

4. The polypeptide of claim 1 further comprising a chemical cross-linker.

5. The polypeptide of claim 4 wherein the chemical cross-linker is maleimide or 3-nitro-2-pyridyldithio group.

6. A complex comprising a cargo moiety complexed with a polypeptide comprising a protein transduction domain (PTD) wherein said polypeptide is capable of complexing with said cargo moiety and wherein the PTD comprises Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1), and wherein the complex can traverse a cellular membrane.

7. The complex of claim 6 wherein the cargo moiety is selected from the group consisting of a small molecule, a nucleic acid, and a polypeptide.

8. The complex of claim 7 wherein the cargo moiety is a small molecule, wherein the small molecule is selected from the group consisting of a fluorescent marker, a dye, and a pharmaceutical agent.

9. The complex of claim 6 wherein said polypeptide comprising said PTD is a fusion protein.

10. The complex of claim 7 wherein the cargo moiety is a small molecule, wherein the small molecule comprises a radionuclide.

11. The complex of claim 6 wherein the cargo moiety is β-galactosidase or alkaline phosphatase.

12. A conjugate comprising a polypeptide with a protein transduction domain (PTD) linked to a cargo moiety, wherein the PTD comprises Arg-Lys-Met-Leu-Lys-Ser-Thr-Arg-Arg-Gln-Arg-Arg (SEQ ID NO:1), and wherein the conjugate can traverse a cellular membrane.

13. The conjugate of claim 12 , wherein the cargo moiety is selected from the group consisting of a small molecule, a nucleic acid, and a polypeptide.

14. The conjugate of claim 12 , wherein the conjugate comprises a fusion protein.

15. The conjugate of claim 12 , wherein the cargo moiety is β-galactosidase or alkaline phosphatase.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2008
From: CAMBREX BIO SCIENCE WALKERSVILLE
To: LONZA WALKERSVILLE INC.
Reel/Frame 020627/0865 →
Continuity (2)
Provisional Application 6045124300 · Mar 4, 2003
Related Publication 20040209797A1 · Oct 21, 2004